Testing effectiveness (Phase 2)Study completedNCT00006052What this trial is testingSTI571 in Treating Patients With Accelerated Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia Novartis
Testing effectiveness (Phase 2)Study completedNCT00002833What this trial is testingPeripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes M.D. Anderson Cancer Center 53
Not applicableLooking for participantsNCT05282108What this trial is testingEfficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Hikma Pharmaceuticals LLC 240
Not applicableLooking for participantsNCT01281735What this trial is testingInternational Chronic Myeloid Leukemia Pediatric StudyWho this might be right forChronic Myeloid Leukemia Poitiers University Hospital 750
Not applicableStudy completedNCT00632255What this trial is testingLong Term Therapy With Imatinib: Development of Late Side Effects and Compliance to TreatmentWho this might be right forChronic Myeloid LeukemiaNewly Diagnosed Imperial College London 88
Not applicableUnknownNCT05092048What this trial is testingPRO of CML in Real WordWho this might be right forCML (Chronic Myelogenous Leukemia) xuna 10,000
Post-approval studies (Phase 4)WithdrawnNCT01605981What this trial is testingTrial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.Who this might be right forChronic Myeloid Leukemia (CML) Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT00112775What this trial is testingBMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib MesylateWho this might be right forLeukemia Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00001748What this trial is testingHLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological MalignanciesWho this might be right forGraft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableStudy completedNCT00741455What this trial is testingChemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic MalignanciesWho this might be right forHematologic Malignancies Dartmouth-Hitchcock Medical Center 18
Not applicableStudy completedNCT04384848What this trial is testingThe EMPATHY Pilot StudyWho this might be right forLeukemia, Chronic MyeloidCancer Northwestern University 94
Testing effectiveness (Phase 2)Study completedNCT00285259What this trial is testingCytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)Who this might be right forAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more Astellas Pharma Inc 112
Testing effectiveness (Phase 2)Study completedNCT00003396What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396What this trial is testingDepletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic SyndromeWho this might be right forAcute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more Fred Hutchinson Cancer Center 52
Not applicableUnknownNCT01761890What this trial is testingFront-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With DasatinibWho this might be right forChronic Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 147
Testing effectiveness (Phase 2)Study completedNCT00661180What this trial is testingOpen Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to GleevecWho this might be right forChronic Myelogenous Leukemia Bayer 10
Not applicableStudy completedNCT03454503What this trial is testingEffectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in EgyptWho this might be right forPhiladelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase Hikma Pharmaceuticals LLC 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007873What this trial is testingASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Phase Chronic Myelogenous LeukemiaPhiladelphia Chromosome PositiveBCR-ABL1 Positive Chronic Myelogenous Leukemia+1 more M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT06453902What this trial is testingTGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) PatientsWho this might be right forChronic Myeloid LeukemiaAccelerated Phase CML Shenzhen TargetRx Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00003913What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 390